Titre :
  • Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
Auteur : Schrijvers, D ; van Herpen, C M L ; Kerger, Joseph ; Joosens, E ; Van Laer, C ; Awada, Ahmad ; Van Den Weyngaert, Danielle ; Nguyen Huu, C. ; Le Bouder, C ; Castelijns, J A ; Kaanders, J ; de Mulder, Pieter ; Vermorken, Jan Baptist
Informations sur la publication : Annals of oncology, 15, 4, (page 638-645)
Statut de publication : Publié, 2004-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Cisplatin -- administration & dosage
Cisplatin -- adverse effects
Feasibility Studies
Female
Fluorouracil -- administration & dosage
Fluorouracil -- adverse effects
Head and Neck Neoplasms -- drug therapy
Head and Neck Neoplasms -- mortality
Head and Neck Neoplasms -- pathology
Humans
Male
Middle Aged
Nausea -- chemically induced
Neoplasm Staging
Neoplasms, Squamous Cell -- drug therapy
Neoplasms, Squamous Cell -- mortality
Neoplasms, Squamous Cell -- pathology
Stomatitis -- chemically induced
Survival Analysis
Survival Rate
Taxoids -- administration & dosage
Taxoids -- adverse effects
Thrombocytopenia -- chemically induced
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase I
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/15033673